At a glance
- Originator Solvay
- Class Anti-ischaemics; Small molecules
- Mechanism of Action Sodium channel antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders
Most Recent Events
- 30 Apr 1998 Preclinical development for Ischaemic heart disorders in Germany (Unknown route)